Abstruct: Plasma rich in growth factors (PRGF) had been used in regenerative therapy such as soft tissue and newly bone formation. However, there has been little basic research into the efficacy of PRGF in bone regeneration. In this study, we evaluated the efficacy for new bone formation by transplantation of PRGF onto rat calvaria. The osteogenic potential was evaluated by histologic findings, immunohistochemistry and bone formation analyzed with micro-computed tomography (micro-CT). PRGF was prepared by centrifugation of rat whole blood (WB), and then was activated using 10% calcium chloride solution. The activated PRGF transplanted within a polytetrafluoroethylene (PTFE) tube was transplanted onto calvarial bone of rats. Histological observation demonstrated that PRGF group showed newly formed bone in a wide range. Immunohistochemistry showed Runx2, Osterix, Bone Alkaline Phosphatase (BAP) and Osteocalcin expressed in PRGF group during the early stage of bone formation. Micro-CT showed that PRGF group promoted an increase in bone volume which compared to control group. We concluded that PRGF has more capacity for bone regeneration, and PRGF may be useful in bone regeneration treatment.
Introduction
Platelet concentration products, which are autologous constituents of inductive factors obtained from blood, have been known high concentrations of platelets containing various growth factors 1) . Marx reported that the combined use of autogeneous bon e wi th P R P was inc rease d in radi ograp h ic an d histomorphometric bone density 2) . PRP has been used in bone augmentation for dental implants or trauma [2] [3] [4] [5] . However, it has been shown that PRP formulations have different biological activities, depending on their various protocol because PRP preparation for different from Marx's protocol and machines [6] [7] [8] .
Plasma rich in growth factors (PRGF) system is one of the methods for preparing platelet concentration 9, 10) , has several advantages including the enhancement of bone regeneration and rapid soft tissue healing 11) . This system is advantageous as it requires one step of centrifugation and is leukocyte-free, thus avoiding higher levels of pro-inflammatory cytokines 3) . In addition, PRGF contains high levels growth factors such as TGF-β and VEGF, which are associated with bone regeneration 9, 12) . However, there has been little basic research into the efficacy of PRGF in bone regeneration 9) .
The aim of this study was to evaluate the efficacy for bone formation in transplantation of PRGF using histologic findings, immunohistochemistry and micro-CT analysis.
Materials and Methods

Preparations for PRGF
Twelve male Sprague-Dawley rats (15 weeks old) were obtained from Nihon SLC, Shizuoka, Japan and housed in isolation cages throughout the experimental period. The rats were fed a standardized diet (MF, Oriental Yeast Co., LTD.) and filtered tap water, and maintained under a 12h light/dark cycle at a temperature of 23±1 °C and relative humidity of 60±10 %.
Following a one week preliminary period, the general well-being of the rats was checked and body weight was measured. Rats weighing 405-415 g in a healthy condition and with normal growth were used in this study. Rat whole blood (5 ml) was collected % sodium citrate as an anticoagulant (BTI Biotechnology Institute, Vitoria, Spain). PRGF was prepared from whole blood (WB) centrifuged in accordance with Anitua's protocol 9, 10, 13) . Briefly, tubes were centrifuged at 460 × g for 8 min. The bottom fraction containing erythrocytes and the top fraction containing platelets are separated by the whitish buffy coat, which contains leukocytes. The plasma fraction (1 ml over the buffy coat) was collected as Fraction 2 (F2), while Fraction 1 (F1) was the layer above F2. The experimental procedures of this study were conducted under protocols approved by the Animal Care and Ethics Committee in accordance with Nihon University School of Dentistry at Matsudo guidelines (No: AP12MD018).
Transplantation procedure
The transplantation procedure was designed to evaluate newly formed bone in the presence of PRGF F2 in vivo. Rats were randomly divided into three groups (n = 3 per group); Control group (PTFE tube only) and PRGF group (PRGF F2 in PTFE tube). All animals induced with 3% sevoflurane and maintained at 2% sevoflurane, and surgical site was aseptically prepared. PRGF F2 transplanted onto rat calvaria. A previous study reported that PRGF F2 had a higher platelet concentration and growth factors compared with PRGF F1 9, 13) . Platelets in PRGF F2 were activated using 10 % calcium chloride solution just prior to use ( Fig. 1A) 9, 13) . Transplantation into rats was performed as in previous reports 14, 15) . Briefly, a linear skin incision was made along the edge of the skull with a #15 surgical blade. The periosteum of the calvaria was carefully removed with a raspatorium after elevation of the skin-periosteum flap. PRGF F2 was inserted into PTFE tubes (inner diameter, 3 mm; outer diameter, 4 mm; height, 2 mm) ( Fig. 1B) , which were then placed on the calvarial surface ( Fig. 1C ). Overlying tissue was closed with sutures ( Fig. 1D ).
Histologic analysis
Rats were sacrificed 2 and 8 weeks after transplantation. The calvarial bone area including the PTFE tube was extirpated en bloc. Samples were fixed in 10% neutral-buffered formalin solution, decalcified in 10% EDTA (pH 7.0) and embedded in paraffin. Semi-serial sections (4 μm) were obtained in the sagittal orientation. Sections were stained with hematoxylin and eosin (H-E) and observed by light microscopy. Newly formed bone was defined that bone-like hard tissue arranged regularly the osteoblast between the cortical bone and periosteum.
Immunohistochemical analysis
Sections of calvarial bone including the PTFE tube from all groups were immunohistochemically stained. Sections were deparaffinized and endogenous peroxidase activity was quenched by incubation in 3 % H 2 O 2 in methanol at room temperature for 15 min. Sections were washed with PBS (Phosphate buffered saline) and were incubated with goat polyclonal antibody against rat Runx2 (1:50; sc-12488; SANTA CRUZ, Tokyo, Japan), rabbit 
Results
Histologic findings
Newly formed bone was observed between the periosteum and cortical bone in the PRGF group at 2 weeks after transplantation ( Fig. 2B, D) . However, little newly formed bone was observed control group ( Fig. 2A, C) . As compared to control groups, the PRGF group showed a wide range of newly formed bone at 8 weeks after surgery ( Fig. 2F, H ). In addition, osteoblasts were observed around the cortical and newly formed bone ( Fig.   2D , G, H).
Immunohistological findings
Immunohistochemical findings for Runx2, Osterix, BAP and
Osteocalcin are shown in Fig. 3 . Osteoblasts positive for Runx2 and Osterix were seen in the margin of newly formed bone in all experimental groups, and positive osteocytes were seen around newly formed bone in the PRGF group at 2 weeks ( Fig. 3A-D) .
Numerous swollen spindle-shaped cells in the connective tissue were positive for Runx2 ( Fig. 3A, B) and Osterix (Fig. 3C, D ).
BAP and Osteocalcin ( Fig. 3E -H) staining was also seen in osteoblasts arranged in the margin, and in osteocytes around newly formed bone in the PRGF group at 2 weeks (Fig. 3F, H) . However, BAP and Osteocalcin staining was negative in the control group at 2 weeks (Fig. 3E, G) Immune complexes were visualized using 3'3'-diamibobenzidine tetrachloride (DAB; Merck, Darmstat, Germany). Immunostained sections were then counterstained with Mayer's hematoxylin.
Normal bone was used as a positive control in immunochemical staining, and negative controls were prepared with by omitting primary antibody 16) .
Micro-CT analysis of transplants
Quantitative image analysis of new bone formation was performed using an in vivo micro-CT system (Rigaku-mCT, Tokyo, Japan). Calvarial bone at the PTFE tube site was scanned using a micro-CT system with an X-ray source of 90 kV/150 μA at 2 and 8 weeks after transplantation. Imaging of newly formed bone in the area containing the inner cavity of the PTFE tube was then performed over a full 360º, with an exposure time of 2 minutes.
An isotropic resolution of 20×20×20 μm voxels was selected, which displayed the microstructure of new bone formation in rats. 
Statistical analysis
Data are expressed as means ± SD of two samples. Significance of differences between culture samples was determined by Welch's t-test and a value of p<0.05 was considered to be statistically significant. in all groups at 8 weeks ( Fig. 3I-P) . (Fig. 4A, B) . A small volume of newly formed bone was seen in the PRGF group when compared with the control group ( Fig. 4A, B ). Newly formed bone area increased inside the PTFE tube after 8 week, as compared to after 2 weeks ( Fig. 4A-D) . In addition, the newly formed bone area increased inside the PTFE tube in the PRGF group when compared to the control group (Fig.   4C, D) . Furthermore, the PRGF group showed newly formed bone in the PTFE tube center area at 8 weeks (Fig. 4D ). We next analyzed the BMD, BMC and BV using micro-CT ( Fig. 5 ). BMD did not differ among the three experimental groups at 2 and 8 weeks (Fig. 5A, D) . The values for BMC and BV were higher in the PRGF group when compared to the control group at 8 weeks ( Fig. 5E, F) , although the values for BMC and BV did not differ in the PRGF group when compared to the control group at 2 weeks ( Fig. 5B, C) .
Micro-CT analysis
Discussion
Platelet concentration product such as PRP is frequently applied to bony defects. This product is readily and rapidly obtained from patient blood, and because it is 100 % autologous products, this is no immunological concerns regarding their use.
In addition, PRGF contains several growth factors for guided tissue regeneration 17) . In this study, we demonstrated the advantageous for new bone formation by transplantation of PRGF onto rat calvaria.
PRGF group showed highly newly formed bone compared to control group in histologic findings (Fig. 2) . Immunohistological observations revealed that Runx2, Osterix, BAP and Osteocalcin were expressed in osteocytes around the newly formed bone (Fig.   3 ). Runx2 and Osterix, which are transcription factors that are critical for bone formation [18] [19] [20] , were detected in all experimental groups. Runx2 and osterix play essential roles in the pluripotent mesenchymal cells to the osteoblastic lineage 20, 21) . BAP and Osteocalcin were detected in the PRGF groups earlier than those of control group, but control group at 2 weeks showed negative reactions. BAP and Osteocalcin are known to be involved in osteogenic differentiation, and are secreted by osteoblasts after bone calcification starts 22) . BAP and Osteocalcin are also associated with the turnover phenomenon when bone resorption and formation are occurring stimultaneously 23, 24) . This suggests that the control group at 2 weeks showed no BAP and Osteocalcin because bone calcification had not started. In addition, immunohistochemical staining for Runx2, Osterix, BAP and Osteocalcin was positive reaction in PRGF and control group at 8 weeks. The micro-CT analysis also showed the newly formed bone area was higher in PRGF group than control. The analysis resulted significant differences in BV and BMC when compared with the control group at 8 weeks (Fig. 5 ). Micro-CT analysis and histological observation demonstrated that the PRGF group had large amounts of new bone structure when compared with the control group, while showing the same bone mineral density.
Some reports have shown that PRGF contains high levels of growth factors in humans 9, 10) . It is known that platelets release substances and promote tissue repair, as well as influence the reactivities of vascular and other blood cells in angiogenesis and inflammation 25) . Platelets also contain storage pools of growth factors, including TGF-β and VEGF, as well as cytokines including proteins 25) . Briefly, PRGF fibrin membrane includes various growth factors such as TGF-β and VEGF involved in new bone formation stage 9, 12) . TGF-β stimulates osteogenic differentiation in bone marrow mesenchymal stem cells 26, 27) . VEGF is well known that promote angiogenesis in bone regeneration 28, 29) . The fact that platelets secrete several growth factors and active metabolites means that their use may have a positive influence in clinical situations requiring rapid healing and tissue regeneration 30) . In this study, it might suggest that PRGF is advantageous for new bone formation compared to control because of these growth factors.
In conclusion, histological observation and micro-CT analysis demonstrated that PRGF group enhanced the new bone formation compared to control group. We concluded that transplantation of PRGF is advantageous for new bone formation, and may be useful in bone regeneration treatment.
